Department of Clinical and Molecular Sciences-Histology, Polytechnic University of Marche, Ancona, Italy.
Fertil Steril. 2013 Mar 1;99(3):697-704. doi: 10.1016/j.fertnstert.2012.10.042. Epub 2012 Nov 20.
To assess the physicochemical characteristics of sperm plasma membrane and to evaluate the immunohistochemical expression of transmembrane and cytoskeletal proteins in spermatozoa isolated from normospermic fertile donors and asthenozoospermic infertile patients.
Case-control study.
Academic male infertility center.
PATIENT(S): Twenty-five infertile patients affected by idiopathic asthenozoospermia and 21 age-matched normospermic fertile donors.
INTERVENTION(S): Sperm parameters were evaluated; membrane fluidity and hydration studies, and immunohistochemical analysis were performed in isolated spermatozoa.
MAIN OUTCOME MEASURE(S): Semen analyses to ascertain volume, sperm count, motility, and morphology; then membrane fluidity and hydration studies and immunohistochemical analysis were performed on isolated spermatozoa.
RESULT(S): Spermatozoa from the asthenozoospermic group exhibited a reduced fluidity at the lipid-water interface level, an increased fluidity of the deeper portion of the bilayer, and a lower plasma membrane hydration than normospermic cells. Moreover, the immunohistochemical expression of ezrin, Cdc42, CD9, F-actin, and β-tubulin was higher in normospermic samples.
CONCLUSION(S): Our results together assume that a cytoskeletal reorganization induced by a disturbance in the physicochemical features of sperm plasma membrane, and potentially mediated by ezrin, Cdc42, and tetraspanin CD9, could have a role in idiopathic asthenozoospermia.
评估精子质膜的理化特性,并评估从正常精子生育能力的供体和弱精子症不育患者中分离的精子中跨膜和细胞骨架蛋白的免疫组织化学表达。
病例对照研究。
学术男性不育中心。
25 名患有特发性弱精子症的不育患者和 21 名年龄匹配的正常精子生育能力的供体。
评估精子参数;在分离的精子中进行膜流动性和水合作用研究以及免疫组织化学分析。
精液分析以确定体积、精子计数、活力和形态;然后对分离的精子进行膜流动性和水合作用研究以及免疫组织化学分析。
弱精子症组的精子表现出脂质-水界面水平的流动性降低、双层更深部分的流动性增加以及质膜水合作用降低。此外,正常精子样本中 ezrin、Cdc42、CD9、F-肌动蛋白和β-微管蛋白的免疫组织化学表达更高。
我们的结果共同假设,由精子质膜理化特性的改变引起的细胞骨架重组,可能由 ezrin、Cdc42 和四跨膜蛋白 CD9 介导,可能在特发性弱精子症中起作用。